Showing results (371-380 of 632) with videos related to

Sort By:
Pageof 64
AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.
AIDS (London, England)|June 1, 1994
A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study GroupA N Phillips, F Antunes, G Stergious, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 10, 2017
Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?C Ekenberg, I P Lodding, N E Wareham, et al.
AIDS (London, England)|January 29, 2014
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosisDaniel Grint, Lars Peters, Juergen K Rockstroh, et al.
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
AIDS (London, England)|February 19, 2005
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimenChristian Holkmann Olsen, Jose Gatell, Bruno Ledergerber, et al.
Cells|December 23, 2022
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut MicrobiomeRamtin Zargari Marandi, Mette Jørgensen, Emma Elizabeth Ilett, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Pageof 64